Published in Anaesthesia on January 01, 1969
Value of an ACTH test in assessing hypothalamic-pituitary-adrenocortical function in glucocorticoid-treated patients. Br Med J (1973) 1.43
Depression of lymphocyte responses after surgical trauma. Br J Exp Pathol (1973) 1.29
Comparison of effects of long-term corticotrophin and corticosteroid treatment on responses of plasma growth hormone, ACTH, and corticosteroid to hypoglycaemia. Br Med J (1974) 1.21
Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem. Ann Surg (1994) 1.08
Blood spot glucocorticoid concentrations in ill preterm infants. Arch Dis Child (1987) 1.08
Adaptation during surgical stress. A reevaluation of the role of glucocorticoids. J Clin Invest (1986) 0.93
Modification of plasma corticosteroid concentrations during and after surgery by epidural blockade. Br Med J (1973) 0.83
A rational regimen for perioperative steroid supplements and a clinical assessment of the requirement. Ann R Coll Surg Engl (1981) 0.80
Recovery of Adrenal Function in Patients with Glucocorticoids Induced Secondary Adrenal Insufficiency. Endocrinol Metab (Seoul) (2016) 0.76
Anesthetic Management of a Patient With Takayasu Arteritis. Anesth Prog (2016) 0.75
Abnormal growth hormone release in response to human pancreatic growth hormone releasing factor in acromegaly. Br Med J (Clin Res Ed) (1983) 0.75
Testing the hypothalamic-pituitary-adrenal axis. Br Med J (1970) 0.75
Absorption by non-smokers of carbon monoxide from room air polluted by tobacco smoke. Lancet (1973) 5.52
Thyrotrophin-releasing hormone as a thyroid-function test. Lancet (1971) 4.34
The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus. Lancet (1972) 3.10
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet (2002) 3.07
Cardiovascular effects of implanted acrylic bone cement. Br Med J (1971) 3.05
Smoking during pregnancy and its effects on the fetus. J Obstet Gynaecol Br Commonw (1972) 2.91
Plasma nicotine levels after smoking cigarettes with high, medium, and low nicotine yields. Br Med J (1975) 2.80
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65
Comparison of effect on tobacco consumption and carbon monoxide absorption of changing to high and low nicotine cigarettes. Br Med J (1973) 2.65
Effect of nicotine chewing gum on smoking behaviour and as an aid to cigarette withdrawal. Br Med J (1976) 2.41
Vasopressin analogue DDAVP in diabetes insipidus: clinical and laboratory studies. Br Med J (1973) 2.41
Adrenocorticotrophic action of long-acting tetracosactrin compared with corticotrophin-gel. Br Med J (1967) 2.39
Inhalation of tobacco smoke by pipe and cigar smokers. Lancet (1973) 2.39
Blood carboxyhaemoglobin, plasma thiocyanate, and cigarette consumption: implications for epidemiological studies in smokers. Br Med J (Clin Res Ed) (1982) 2.32
Plasma nicotine levels after cigarette smoking and chewing nicotine gum. Br Med J (1976) 2.31
A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab (1999) 2.30
Carboxyhaemoglobin and plasma thiocyanate: complementary indicators of smoking behaviour? Thorax (1982) 2.30
Long-term treatment of acromegaly with bromocriptine. Br Med J (1977) 2.18
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med (2000) 2.16
Adjustment of smokers to dilution of tobacco smoke by ventilated cigarette holders. Clin Pharmacol Ther (1978) 2.09
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet (2001) 2.08
Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine. Br Med J (1972) 2.07
Long-term treatment of galactorrhoea and hypogonadism with bromocriptine. Br Med J (1974) 1.98
Increased beta-endorphin but not met-enkephalin levels in human cerebrospinal fluid after acupuncture for recurrent pain. Lancet (1980) 1.94
Cloning and characterization of cDNAs encoding human gastrin-releasing peptide. Proc Natl Acad Sci U S A (1984) 1.93
Clinical studies of multiple endocrine neoplasia type 1 (MEN1) QJM (1996) 1.93
Variations in carboxyhaemoglobin levels in smokers. Br Med J (1974) 1.87
Comparison of increases in carboxyhaemoglobin after smoking "extra-mild" and "non-mild" cigarettes. Lancet (1973) 1.84
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Bromocriptine treatment of acromegaly. Br Med J (1975) 1.70
Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf) (1993) 1.69
Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. Lancet (1973) 1.68
Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer. Br Med J (Clin Res Ed) (1983) 1.67
Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction. Br Med J (1973) 1.66
Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf) (1986) 1.62
Apathetic T-3 toxicosis. Br Med J (1974) 1.61
Interaction between secretion of the gonadotrophins, prolactin, growth hormone, thyrotrophin and corticosteroids in man: the effects of LH FSH-RH, TRH and hypoglycaemia alone and in combination. Clin Endocrinol (Oxf) (1973) 1.60
Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet (1998) 1.59
Cyanide and thiocyanate concentrations following sodium nitroprusside infusion in man. Br J Anaesth (1976) 1.54
Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab (2000) 1.52
Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med (1989) 1.52
Pituitary-adrenal function in severe depressive illness. Lancet (1968) 1.52
Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest (1995) 1.49
Bromocriptine treatment of female infertility: report of 13 pregnancies. Br Med J (1975) 1.49
Letter: Metaclopramide and prolactin. Br Med J (1974) 1.48
Plasma prolactin activity in inappropriate lactation. Br Med J (1971) 1.46
Immunoreactive corticotrophin levels in adrenocortical insufficiency. Br Med J (1971) 1.46
Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study. Clin Endocrinol (Oxf) (2000) 1.45
Cushing's syndrome. Clin Endocrinol Metab (1985) 1.44
Colorectal neoplasia in acromegaly. Gut (1999) 1.42
Lymphocytic hypophysitis: unusual features of a rare disorder. Clin Endocrinol (Oxf) (1995) 1.41
The relationship between serum prolactin and immunocytochemical staining for prolactin in patients with pituitary macroadenomas. Clin Endocrinol (Oxf) (1985) 1.40
Late diagnosis of pituitary and parapituitary lesions causing visual failure. Br Med J (Clin Res Ed) (1986) 1.40
Identification of olfactory dysfunction in carriers of X-linked Kallmann's syndrome. Clin Endocrinol (Oxf) (1994) 1.39
The release of leptin and its effect on hormone release from human pituitary adenomas. Clin Endocrinol (Oxf) (2001) 1.39
Bilateral testicular tumours in congenital adrenal hyperplasia: a continuing diagnostic and therapeutic dilemma. Clin Endocrinol (Oxf) (1989) 1.38
The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis. J Clin Endocrinol Metab (1996) 1.38
Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab (2001) 1.37
Nicotine chewing gum as a substitute for smoking. Br Med J (1977) 1.36
Bromocriptine in management of large pituitary tumours. Br Med J (Clin Res Ed) (1982) 1.36
Smoking and arterial reconstruction. Br J Surg (1981) 1.34
Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet (1995) 1.32
Prolactinomas. Br Med J (Clin Res Ed) (1985) 1.32
Development of a specific extracted radioimmunoassay for methionine enkephalin in human plasma and cerebrospinal fluid. J Endocrinol (1980) 1.31
Development and validation of a specific radioimmunoassay for somatostatin in human plasma. Ann Clin Biochem (1979) 1.26
Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography. Eur J Endocrinol (2003) 1.26
beta-Endorphin in human cerebrospinal fluid. Lancet (1978) 1.26
Comparative effects of atmospheric pollution and cigarette smoking on carboxyhaemoglobin levels in man. Nature (1975) 1.26
Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab (2000) 1.26
Influence of amphetamines on plasma corticosteroid and growth hormone levels in man. Br Med J (1969) 1.25
Amenorrhoea, galactorrhoea, and primary hypothyroidism with high circulating levels of prolactin. Br Med J (1971) 1.25
Growth hormone release inhibiting hormone in acromegaly. Br Med J (1974) 1.24
Met-enkephalin circulates in human plasma. Nature (1980) 1.23
Acupuncture in heroin addicts; changes in Met-enkephalin and beta-endorphin in blood and cerebrospinal fluid. Lancet (1979) 1.22
Tumor and plasma ACTH concentrations in patients with and without the ectopic ACTH syndrome. Clin Endocrinol (Oxf) (1972) 1.21
Carbon monoxide yields of cigarettes and their relation to nicotine yield and type of filter. Br Med J (1975) 1.20
Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer. Br Med J (Clin Res Ed) (1985) 1.19
Metyrapone in long-term management of Cushing's disease. Br Med J (1977) 1.19
Galactorrhoea. Br Med J (1972) 1.19
Angiotropic large cell lymphoma (ALCL): morphological, immunohistochemical and genotypic studies with analysis of previous reports. Hematol Oncol (1989) 1.18
Dissociation of the disappearance of bioactive and radioimmunoreactive ACTH from plasma in man. J Clin Endocrinol Metab (1971) 1.18
Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet (1978) 1.18
Hormonal responses to synthetic luteinizing hormone and follicle stimulating hormone-releasing hormone in man. Br Med J (1972) 1.17
Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration. Clin Endocrinol (Oxf) (2000) 1.17
Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary. Clin Endocrinol (Oxf) (1984) 1.15
Intracardiac metastases from neuroendocrine tumours. Clin Endocrinol (Oxf) (1997) 1.14
Plasma levels of immunoreactive corticotrophin in patients with Cushing's syndrome. Br Med J (1968) 1.14
Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome. Eur J Endocrinol (2003) 1.13
Deterioration of severe Graves' ophthalmopathy during cyclosporin treatment. Lancet (1984) 1.12
Alcohol-induced pseudo-Cushing's syndrome. Lancet (1977) 1.12
Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours. Clin Endocrinol (Oxf) (2006) 1.11
A comparison of the insulin tolerance/glucagon test with the short ACTH stimulation test in the assessment of the hypothalamo-pituitary-adrenal axis in the early post-operative period after hypophysectomy. Clin Endocrinol (Oxf) (1997) 1.11
Isolated pituitary gonadotrophin deficiency: gonadotrophin secretion after synthetic luteinizing hormone and follicle stimulation hormone-releasing hormone. Br Med J (1972) 1.10
Plasma immunoreactive corticotrophin and lipotrophin in Cushing's syndrome and Addison's disease. Br Med J (1977) 1.10
The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells. Clin Endocrinol (Oxf) (1979) 1.08
Treatment of prolactinomas with megavoltage radiotherapy. Br Med J (Clin Res Ed) (1984) 1.08
Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome. Clin Endocrinol (Oxf) (1991) 1.08
Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy. Lancet (1979) 1.08
Transient amaurosis and headache after thyrotropin releasing hormone. Lancet (1982) 1.08